ANGELA HOWARD WAS NOT EXPECTED TO LIVE PAST CHILDHOOD. DIAGNOSED WITH SICKLE CELL DISEASE AT AGE 2, HER DOCTORS AND NURSES PREDICTED THE PAINFUL DISEASE WOULD KILL HER BY AGE 18. NOW 52, HOWARD HAS DEDICATED HER LIFE TO EDUCATING THE PUBLIC ABOUT THE STIGMA AND MISUNDERSTANDING ASSOCIATED WITH SICKLE CELL DISEASE.

She is not alone in this fight. A commission report from The Lancet Haemotology outlines the global burden caused by sickle cell disease and identifies the need for important governmental commitments and investments and makes health care-related and education recommendations experts say would improve outcomes for those living with the blood disorder, which mainly occurs in the Black population.

UF College of Nursing researcher Diana Wilkie, PhD, RN, FAAN, the Prairieview Trust – Earl and Margo Powers Endowed Professor, is a co-author of the commission report, published in July. The commission includes 33 co-authors comprising experts in sickle cell disease, as well as patients and activists from around the world.

Sickle cell disease is an inherited disorder that changes red blood cells into a C shape. People with sickle cell disease report being stigmatized due to their race and because they may be seen as drug seekers or addicts when they pursue medications to control pain.

“It is critical for individuals with sickle cell disease or sickle cell trait to understand the genetic inheritance of the disease and to know about reproductive options that will allow them, if it is their wish, to avoid their child being born with sickle cell disease,” Wilkie said. “On the other hand, it is just as important for health care workers to believe people who say they are in pain and to give them appropriate therapies to control it. We need a workforce educated about sickle cell disease and committed to eliminating the stigma and health disparities of this disease.”

The Lancet Haematology Commission’s report calls for the global standardization of collecting routine epidemiological data by the year 2025 and, further, for countries to be held accountable for public health intervention measures and progress. Most people with sickle cell disease are not properly diagnosed until the onset of symptoms. Conducting mandatory newborn screenings would allow for treatment to be provided before symptoms develop.

Another recommendation involves the accessibility of effective treatment and further development of innovative treatment methods. Penicillin, the drug hydroxyurea and blood transfusions are all effective but are not available in low-income countries where sickle cell disease is prevalent. The commission implores governments to give people access to a minimum standard of health care regardless of where they live. Additionally, access to innovative treatments, like stem-cell transplantation and gene therapies, should be expanded and studies accelerated to provide safe, accessible and affordable cures globally by the year 2040.

“When I was a child, they didn’t really know much about sickle cell,” Howard said. “It was considered an orphan disease. I’ve lived to be an adult, but I think a lot of that has to do with me becoming educated about my disease and learning the things that trigger a crisis.”

For furthering education, Wilkie points to the current work taking place at the College of Nursing, including her own CHOICES project — a web-based educational tool that helps young adults understand sickle cell disease and prevent it from being inherited — and self-management interventions from Professor Miriam Ezenwa, PhD, MSN, RN, FAAN, that help improve pain management.